Laurel Wealth Advisors (California)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.11M | Buy |
2,018
+1,272
| +171% | +$700K | 0.11% | 195 |
|
|
2022
Q3 | $379K | Sell |
746
-17
| -2% | -$8.64K | 0.04% | 411 |
|
|
2022
Q2 | $415K | Sell |
763
-93
| -11% | -$50.6K | 0.04% | 408 |
|
|
2022
Q1 | $506K | Sell |
856
-34
| -4% | -$20.1K | 0.04% | 406 |
|
|
2021
Q4 | $594K | Buy |
890
+216
| +32% | +$144K | 0.05% | 393 |
|
|
2021
Q3 | $385K | Sell |
674
-179
| -21% | -$102K | 0.07% | 288 |
|
|
2021
Q2 | $431K | Sell |
853
-30
| -3% | -$15.2K | 0.06% | 312 |
|
|
2021
Q1 | $403K | Buy |
883
+46
| +5% | +$21K | 0.06% | 293 |
|
|
2020
Q4 | $390K | Hold |
837
| – | – | 0.06% | 293 |
|
|
2020
Q3 | $369K | Sell |
837
-3
| -0.4% | -$1.32K | 0.06% | 269 |
|
|
2020
Q2 | $305K | Sell |
840
-28
| -3% | -$10.2K | 0.06% | 282 |
|
|
2020
Q1 | $246K | Buy |
868
+5
| +0.6% | +$1.42K | 0.06% | 309 |
|
|
2019
Q4 | $280K | Sell |
863
-451
| -34% | -$146K | 0.05% | 355 |
|
|
2019
Q3 | $383K | Buy |
1,314
+330
| +34% | +$96.2K | 0.07% | 300 |
|
|
2019
Q2 | $289K | Buy |
984
+22
| +2% | +$6.46K | 0.06% | 308 |
|
|
2019
Q1 | $263K | Sell |
962
-30
| -3% | -$8.2K | 0.06% | 308 |
|
|
2018
Q4 | $221K | Sell |
992
-10
| -1% | -$2.23K | 0.07% | 299 |
|
|
2018
Q3 | $244K | Sell |
1,002
-290
| -22% | -$70.6K | 0.06% | 329 |
|
|
2018
Q2 | $267K | Sell |
1,292
-39
| -3% | -$8.06K | 0.07% | 287 |
|
|
2018
Q1 | $274K | Sell |
1,331
-88
| -6% | -$18.1K | 0.08% | 264 |
|
|
2017
Q4 | $269K | Buy |
1,419
+284
| +25% | +$53.8K | 0.08% | 276 |
|
|
2017
Q3 | $214K | Buy |
+1,135
| New | +$214K | 0.07% | 278 |
|